DataMeds AI (MEDS) Operating Income (2024 - 2026)

DataMeds AI (MEDS) has reported Operating Income for 3 consecutive years, with -$6.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Operating Income rose 80.81% year-over-year to -$6.0 million; the trailing twelve-month figure through Mar 2026 stood at -$68.4 million (down 82.86% YoY), and the FY2025 full-year result was -$93.7 million, down 1425.58% from the prior year.
• Operating Income improved to -$6.0 million in Q1 2026 per MEDS's latest filing, from -$25.4 million in the prior quarter.
• Across five years, Operating Income topped out at -$79764.0 in Q1 2024 and bottomed at -$31.5 million in Q3 2025.
• Historically, Operating Income has averaged -$11.8 million across 3 years, with a median of -$5.5 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Operating Income tumbled 39201.4% in 2025, then soared 80.81% in 2026.
• Over 3 years, Operating Income stood at -$3.7 million in 2024, then slumped by 576.5% to -$25.4 million in 2025, then soared by 76.27% to -$6.0 million in 2026.
• According to Business Quant data, Operating Income over the past three periods registered -$6.0 million, -$25.4 million, and -$31.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.